<DOC>
	<DOC>NCT01607593</DOC>
	<brief_summary>This is a multicenter retrospective study to investigate the dosage regimens of sertraline in the treatment of Posttraumatic Stress Disorder (PTSD) under current medical practice and the efficacy and safety of this drug in patients with PTSD. Data will be collected from the medical records of patients with PTSD.</brief_summary>
	<brief_title>A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients</brief_title>
	<detailed_description>Patients with PTSD who have been dosed with sertraline from July 2006 (i.e., the start of marketing of this drug in Japan) or later to before contracting with each investigational site.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders, Traumatic</mesh_term>
	<mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Patients with PTSD who have been dosed with sertraline since July 2006 or later. Patients must be Japanese. Patients should be started before the conclusion of a contract with each investigational site.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Retrospective</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Posttraumatic stress disorder</keyword>
</DOC>